Why Bending Spoons Stock Popped Today

Berkshire Hathaway announced an additional $330 million investment in Bending Spoons, buying 10 million shares at $33 each—a 13% discount to Tuesday’s close—and lifting its stake to 4%; Bending Spoons shares rose 35.4% by 10:35 a.m. ET Wednesday. The article cites $453 million in trailing-12-month free cash flow and analyst expectations for 55% annual earnings growth over five years, but notes valuations above 16x sales, 130x earnings and 73x free cash flow. It describes further upside potential while cautioning that the easy gains may already have been made and better bargains may exist elsewhere.

Analysis

The key market mechanism is signaling, not a near-term change in Bending Spoons’ cash flows: Berkshire’s participation can broaden the buyer base, while the sharp repricing against a discounted private purchase risks turning the transaction into a momentum catalyst. The $33 placement price is not a reliable floor; it may reflect different liquidity or transaction terms, and the discount itself underscores that public buyers are paying materially more. At the cited valuation, the thesis depends on earnings compounding and free-cash-flow durability, not merely on Berkshire’s endorsement. Analyst growth expectations are especially vulnerable if acquisition-related accounting, integration costs, or cash conversion diverge from reported earnings; verify organic growth and the source and repeatability of free cash flow. In the next 1–3 months, filings on share supply, lockups, and any further insider or investor sales matter more than the endorsement headline. Over 6–18 months, execution against growth expectations and cash generation should dominate. For Berkshire, the stake is unlikely to be a meaningful consolidated earnings catalyst absent a much larger commitment. Contrarian view: the quality/signaling premium may persist, but the post-jump entry leaves little cushion if growth disappoints.

Key Decisions for Investors

• Avoid chasing BSP immediately after the repricing. Reassess after the next results and disclosures on organic growth, free-cash-flow conversion, and share-sale restrictions; treat $33 as a reference point, not technical support.
• For existing BSP holders, consider trimming into further sharp strength rather than assuming Berkshire’s purchase validates the public-market valuation. The thesis weakens if growth guidance or cash conversion falls short, or if filings reveal meaningful near-term supply.
• Do not use BRK.A as a proxy trade for BSP: the disclosed investment alone is not a clear driver of Berkshire’s consolidated earnings or valuation.
• Watch for a pullback alongside stable operating metrics as a possible better entry; avoid initiating a short solely on valuation, since endorsement-driven momentum and limited available float—if confirmed—could extend the move.